Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Marinus Pharma CS (MRNS)

Marinus Pharma CS (MRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 70,865
  • Shares Outstanding, K 54,934
  • Annual Sales, $ 30,990 K
  • Annual Income, $ -141,410 K
  • 60-Month Beta 1.14
  • Price/Sales 2.39
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade MRNS with:

Options Overview Details

View History
  • Implied Volatility 79.74% ( -167.87%)
  • Historical Volatility 505.03%
  • IV Percentile 71%
  • IV Rank 13.53%
  • IV High 372.57% on 04/12/24
  • IV Low 33.91% on 05/20/24
  • Put/Call Vol Ratio 0.01
  • Today's Volume 420
  • Volume Avg (30-Day) 662
  • Put/Call OI Ratio 0.09
  • Today's Open Interest 14,401
  • Open Int (30-Day) 41,580

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.59
  • Number of Estimates 6
  • High Estimate -0.54
  • Low Estimate -0.68
  • Prior Year -0.61
  • Growth Rate Est. (year over year) +3.28%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2700 +3.54%
on 05/20/24
1.7700 -25.71%
on 05/08/24
-0.1250 (-8.68%)
since 04/23/24
3-Month
1.1100 +18.47%
on 04/16/24
10.5000 -87.48%
on 03/01/24
-8.4550 (-86.54%)
since 02/23/24
52-Week
1.1100 +18.47%
on 04/16/24
11.2600 -88.32%
on 01/08/24
-6.4250 (-83.01%)
since 05/23/23

Most Recent Stories

More News
Marinus Pharmaceuticals: Q1 Earnings Snapshot

Marinus Pharmaceuticals: Q1 Earnings Snapshot

MRNS : 1.3200 (+2.33%)
Marinus Pharmaceuticals: Q4 Earnings Snapshot

Marinus Pharmaceuticals: Q4 Earnings Snapshot

MRNS : 1.3200 (+2.33%)
Marinus Pharmaceuticals: Q3 Earnings Snapshot

Marinus Pharmaceuticals: Q3 Earnings Snapshot

MRNS : 1.3200 (+2.33%)
Marinus Pharmaceuticals: Q2 Earnings Snapshot

Marinus Pharmaceuticals: Q2 Earnings Snapshot

MRNS : 1.3200 (+2.33%)
Marinus Pharmaceuticals (MRNS) Reports Q1 Loss, Tops Revenue Estimates

Marinus Pharmaceuticals (MRNS) delivered earnings and revenue surprises of 12.99% and 94.86%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

MRNS : 1.3200 (+2.33%)
VVOS : 2.11 (-0.94%)
Marinus Pharmaceuticals: Q1 Earnings Snapshot

Marinus Pharmaceuticals: Q1 Earnings Snapshot

MRNS : 1.3200 (+2.33%)
4D Molecular Therapeutics, Inc. (FDMT) Reports Q1 Loss, Lags Revenue Estimates

4D Molecular Therapeutics, Inc. (FDMT) delivered earnings and revenue surprises of 0% and 79.49%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

FDMT : 25.09 (-4.02%)
MRNS : 1.3200 (+2.33%)
Earnings Preview: Marinus Pharmaceuticals (MRNS) Q1 Earnings Expected to Decline

Marinus Pharmaceuticals (MRNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MRNS : 1.3200 (+2.33%)
NKTR : 1.6850 (-3.71%)
Marinus Pharmaceuticals to Present at Upcoming Investor Conferences

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that management will present...

MRNS : 1.3200 (+2.33%)
Marinus Pharmaceuticals to Provide Business Update and Report First Quarter 2023 Financial Results on May 11, 2023

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that it plans to release financial...

MRNS : 1.3200 (+2.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Marinus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It is focused on developing and commercializing therapeutics for the treatment of epilepsy and other targeted neurological, behavioral and psychiatric disorders. The Company offers Ganaxolone which has completed Phase II clinical...

See More

Key Turning Points

3rd Resistance Point 1.4700
2nd Resistance Point 1.4300
1st Resistance Point 1.3600
Last Price 1.3200
1st Support Level 1.2500
2nd Support Level 1.2100
3rd Support Level 1.1400

See More

52-Week High 11.2600
Fibonacci 61.8% 7.3827
Fibonacci 50% 6.1850
Fibonacci 38.2% 4.9873
Last Price 1.3200
52-Week Low 1.1100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar